Literature DB >> 28582800

Regulation of CD4 T cells and their effects on immunopathological inflammation following viral infection.

Mitra Bhattacharyya1, Patrick Madden1, Nathan Henning1, Shana Gregory1, Malika Aid2, Amanda J Martinot2, Dan H Barouch2,3, Pablo Penaloza-MacMaster1.   

Abstract

CD4 T cells help immune responses, but knowledge of how memory CD4 T cells are regulated and how they regulate adaptive immune responses and induce immunopathology is limited. Using adoptive transfer of virus-specific CD4 T cells, we show that naive CD4 T cells undergo substantial expansion following infection, but can induce lethal T helper type 1-driven inflammation. In contrast, memory CD4 T cells exhibit a biased proliferation of T follicular helper cell subsets and were able to improve adaptive immune responses in the context of minimal tissue damage. Our analyses revealed that type I interferon regulates the expansion of primary CD4 T cells, but does not seem to play a critical role in regulating the expansion of secondary CD4 T cells. Strikingly, blockade of type I interferon abrogated lethal inflammation by primary CD4 T cells following viral infection, despite that this treatment increased the numbers of primary CD4 T-cell responses. Altogether, these data demonstrate important aspects of how primary and secondary CD4 T cells are regulated in vivo, and how they contribute to immune protection and immunopathology. These findings are important for rational vaccine design and for improving adoptive T-cell therapies against persistent antigens.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  CD4 T cell differentiation; CD4 T cell proliferation; T cell; gene regulation; inflammation

Mesh:

Substances:

Year:  2017        PMID: 28582800      PMCID: PMC5588757          DOI: 10.1111/imm.12771

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  50 in total

1.  Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.

Authors:  Rachael D Aubert; Alice O Kamphorst; Surojit Sarkar; Vaiva Vezys; Sang-Jun Ha; Daniel L Barber; Lilin Ye; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Authors:  Andrew Stamm; Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

3.  Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory.

Authors:  Matthew A Williams; Eugene V Ravkov; Michael J Bevan
Journal:  Immunity       Date:  2008-03-20       Impact factor: 31.745

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection.

Authors:  J Scott Hale; Ben Youngblood; Donald R Latner; Ata Ur Rasheed Mohammed; Lilin Ye; Rama S Akondy; Tuoqi Wu; Smita S Iyer; Rafi Ahmed
Journal:  Immunity       Date:  2013-04-11       Impact factor: 31.745

7.  A vital role for interleukin-21 in the control of a chronic viral infection.

Authors:  John S Yi; Ming Du; Allan J Zajac
Journal:  Science       Date:  2009-05-14       Impact factor: 47.728

8.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

9.  Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.

Authors:  S I Abrams; S F Stanziale; S D Lunin; S Zaremba; J Schlom
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

10.  Interferon-driven deletion of antiviral B cells at the onset of chronic infection.

Authors:  Benedict Fallet; Kerstin Narr; Yusuf I Ertuna; Melissa Remy; Rami Sommerstein; Karen Cornille; Mario Kreutzfeldt; Nicolas Page; Gert Zimmer; Florian Geier; Tobias Straub; Hanspeter Pircher; Kevin Larimore; Philip D Greenberg; Doron Merkler; Daniel D Pinschewer
Journal:  Sci Immunol       Date:  2016-10-21
View more
  9 in total

1.  Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity.

Authors:  Sarah Sanchez; Nicole Palacio; Tanushree Dangi; Thomas Ciucci; Pablo Penaloza-MacMaster
Journal:  Sci Immunol       Date:  2021-12-03

2.  Interrogating Adaptive Immunity Using LCMV.

Authors:  Tanushree Dangi; Young Rock Chung; Nicole Palacio; Pablo Penaloza-MacMaster
Journal:  Curr Protoc Immunol       Date:  2020-09

3.  Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection.

Authors:  Eryn Blass; Malika Aid; Amanda J Martinot; Rafael A Larocca; Zi Han Kang; Alexander Badamchi-Zadeh; Pablo Penaloza-MacMaster; R Keith Reeves; Dan H Barouch
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

Review 4.  Complexities of Type I Interferon Biology: Lessons from LCMV.

Authors:  Tamara Suprunenko; Markus J Hofer
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

5.  TLR4 signaling improves PD-1 blockade therapy during chronic viral infection.

Authors:  Yidan Wang; Young Rock Chung; Simon Eitzinger; Nicole Palacio; Shana Gregory; Mitra Bhattacharyya; Pablo Penaloza-MacMaster
Journal:  PLoS Pathog       Date:  2019-02-06       Impact factor: 6.823

6.  Early type I IFN blockade improves the efficacy of viral vaccines.

Authors:  Nicole Palacio; Tanushree Dangi; Young Rock Chung; Yidan Wang; Juan Luis Loredo-Varela; Zhongyao Zhang; Pablo Penaloza-MacMaster
Journal:  J Exp Med       Date:  2020-12-07       Impact factor: 14.307

7.  Bovine Peripheral Blood Derived Lymphocyte Proteome and Secretome Show Divergent Reaction of Bovine Immune Phenotypes after Stimulation with Pokeweed Mitogen.

Authors:  Kristina J H Kleinwort; Roxane L Degroote; Sieglinde Hirmer; Lucia Korbonits; Lea Lorenz; Armin M Scholz; Stefanie M Hauck; Cornelia A Deeg
Journal:  Proteomes       Date:  2022-02-08

8.  Adoptive B cell therapy for chronic viral infection.

Authors:  Young Rock Chung; Tanushree Dangi; Nicole Palacio; Sarah Sanchez; Pablo Penaloza-MacMaster
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

9.  Effect of Forsythiaside A on the RLRs Signaling Pathway in the Lungs of Mice Infected with the Influenza A Virus FM1 Strain.

Authors:  Xiao Zheng; Yingjie Fu; Shan-Shan Shi; Sha Wu; Yuqi Yan; Liuyue Xu; Yiwei Wang; Zhenyou Jiang
Journal:  Molecules       Date:  2019-11-20       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.